Background: Short but impactful, the two-decade story of gene editing allowed a significant breakthrough in the treatment of haematological malignancies. However, despite different generations of chimeric antigen receptor T (CAR T), such a successful therapy has not yet been replicated in solid tumours and non-oncological diseases. Methods:...
-
2024 (v1)PublicationCAR T therapy from haematological malignancies to aging-related diseases: An ever-expanding universeUploaded on: July 3, 2024
-
2024 (v1)Publication
This editorial discusses the manuscript by Di Maria et al, published in the recent issue of the World Journal of Cardiology. We here focus on the still elusive pathophysiological mechanisms underlying cardio-renal syndrome (CRS), despite its high prevalence and the substantial worsening of both kidney function and heart failure. While the...
Uploaded on: July 18, 2024 -
2024 (v1)Publication
Sepsis is among the most important causes of mortality, particularly within the elderly population. Sepsis prevalence is on the rise due to different factors, including increasing average population age and the concomitant rise in the prevalence of frailty and chronic morbidities. Recent investigations have unveiled a "trimodal" trajectory for...
Uploaded on: February 4, 2024 -
2024 (v1)Publication
No description
Uploaded on: July 3, 2024 -
2024 (v1)Publication
No description
Uploaded on: July 3, 2024 -
2024 (v1)Publication
: The debate surrounding the integration of artificial intelligence (AI) into scientific writing has already attracted significant interest in medical and life sciences. While AI can undoubtedly expedite the process of manuscript creation and correction, it raises several criticisms. The crossover between AI and health sciences is relatively...
Uploaded on: August 29, 2024 -
2024 (v1)Publication
Background and aims: While serum osteopontin (OPN)'s established role in cardiometabolic risk is recognized, its potential as a predictor of metabolic syndrome (MetS) improvement through a urine assay has not yet been demonstrated. In this study, we propose its potential predictive role over a 12-month period of standard care, with the ability...
Uploaded on: July 3, 2024 -
2024 (v1)Publication
Purpose: Pembrolizumab-based regimens are conditioned by the expression of PD-L1, but durable response rate is limited by innate and acquired resistance mechanisms. Here, we focus on osteopontin (OPN), an upfront biomarker of senescence, which closely associated with natural history of non-small cell lung cancer (NSCLC). Methods: Seventy-nine...
Uploaded on: July 3, 2024 -
2024 (v1)Publication
No abstract available.
Uploaded on: February 7, 2024 -
2024 (v1)Publication
No description
Uploaded on: July 3, 2024 -
2024 (v1)Publication
Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9), a factor accelerating the degradation of LDL receptors, was associated with a gender-dependent risk for cardiovascular (CV) events in the general population and with all-cause and CV mortality in two relatively small studies in black Africans and South Korean haemodialysis...
Uploaded on: July 3, 2024 -
2024 (v1)Publication
Background: In patients with kidney failure (KF) undergoing dialysis, neutrophils are dysfunctionally activated. Such chronic activation does not correspond to increased protection against infections and is thought to cause direct vascular damage accounting for the higher incidence of cardiovascular (CV) events. We hypothesized that circulating...
Uploaded on: August 29, 2024 -
2023 (v1)Publication
Diabetic cardiomyopathy (DbCM) is characterized by restrictive pattern and consistent risk of overt heart failure. We here focused osteopontin (OPN), which was tested independently associated with left ventricular diastolic dysfunction (LVDD). Overall, OPN increased with DbCM severity according with the presence of left atrial dilatation, LV...
Uploaded on: February 14, 2024 -
2024 (v1)Publication
Background: Continuously improving cancer-specific survival puts a growing proportion of cancer patients at risk of major adverse cardiovascular events (MACE), but tailored tools for cardiovascular risk prediction remain unavailable. Objectives: To assess a broad panel of cardiovascular biomarkers and risk factors for the prediction of MACE and...
Uploaded on: September 4, 2024